ATE312920T1 - Dna immunisierung gegen chlamydia infektion - Google Patents

Dna immunisierung gegen chlamydia infektion

Info

Publication number
ATE312920T1
ATE312920T1 AT97930277T AT97930277T ATE312920T1 AT E312920 T1 ATE312920 T1 AT E312920T1 AT 97930277 T AT97930277 T AT 97930277T AT 97930277 T AT97930277 T AT 97930277T AT E312920 T1 ATE312920 T1 AT E312920T1
Authority
AT
Austria
Prior art keywords
momp
host
immunization against
dna immunization
chlamydia infection
Prior art date
Application number
AT97930277T
Other languages
English (en)
Inventor
Robert C Brunham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE312920T1 publication Critical patent/ATE312920T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT97930277T 1996-07-12 1997-07-11 Dna immunisierung gegen chlamydia infektion ATE312920T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2160796P 1996-07-12 1996-07-12
PCT/CA1997/000500 WO1998002546A2 (en) 1996-07-12 1997-07-11 Dna immunization against chlamydia infection

Publications (1)

Publication Number Publication Date
ATE312920T1 true ATE312920T1 (de) 2005-12-15

Family

ID=21805154

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930277T ATE312920T1 (de) 1996-07-12 1997-07-11 Dna immunisierung gegen chlamydia infektion

Country Status (9)

Country Link
EP (1) EP0915978B1 (de)
JP (1) JP2000503325A (de)
AT (1) ATE312920T1 (de)
AU (1) AU723235B2 (de)
BR (1) BR9712971A (de)
CA (1) CA2259595C (de)
DE (1) DE69734882T2 (de)
NZ (1) NZ334114A (de)
WO (1) WO1998002546A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344202B1 (en) 1996-07-12 2002-02-05 University Of Manitoba DNA immunization against chlaymdia infection
US6696421B2 (en) 1996-07-12 2004-02-24 University Of Manitoba DNA immunization against chlamydia infection
US6838552B1 (en) 1997-08-14 2005-01-04 Vanderbilt University Diagnosis and management of infection caused by Chlamydia
US6340463B1 (en) 1996-08-14 2002-01-22 Vanderbilt University Identification of antigenic peptide sequences
US20030147924A1 (en) * 1998-07-27 2003-08-07 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000006739A2 (en) * 1998-07-27 2000-02-10 Connaught Laboratories Limited Chlamydia antigens and corresponding dna fragments and uses thereof
MXPA01001090A (es) * 1998-07-27 2002-06-04 Connaught Lab Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
AU5365999A (en) * 1998-08-20 2000-03-14 Connaught Laboratories Limited Nucleic acid molecules encoding pomp91a protein of (chlamydia)
US6403101B1 (en) * 1998-10-28 2002-06-11 Connaught Laboratories Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6403102B1 (en) * 1998-10-29 2002-06-11 Connaught Laboratories Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) * 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ512730A (en) 1998-12-04 2003-12-19 Univ Manitoba A immunization procedure against chlamydia infection using an attenuated bacteria comprsing a plasmid with a major outer membrane protein (MOMP) from chlamydial
US6447779B1 (en) 1998-12-08 2002-09-10 Corixa Corporation Compounds for the diagnosis of Chlamydial infection
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6448234B1 (en) 1998-12-08 2002-09-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6432916B1 (en) 1998-12-08 2002-08-13 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
WO2000034483A2 (en) * 1998-12-08 2000-06-15 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6555115B1 (en) 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
ATE384738T1 (de) * 1998-12-28 2008-02-15 Aventis Pasteur Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2370821A1 (en) * 1999-05-01 2000-11-09 Genaera Corporation Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US6811783B1 (en) 1999-09-07 2004-11-02 Aventis Pasteur Limited Immunogenic compositions for protection against chlamydial infection
ATE384793T1 (de) 1999-09-20 2008-02-15 Aventis Pasteur Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen
US6632663B1 (en) * 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
WO2001046225A2 (en) * 1999-12-22 2001-06-28 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046226A2 (en) * 1999-12-22 2001-06-28 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
ATE463575T1 (de) 1999-12-22 2010-04-15 Aventis Pasteur Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US6919187B2 (en) 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
ATE389020T1 (de) 2000-04-21 2008-03-15 Corixa Corp Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650571T2 (de) * 1985-01-14 1997-02-27 Chiron Corp Hauptprotein der Aussenmembran von Chlamydia

Also Published As

Publication number Publication date
AU723235B2 (en) 2000-08-24
EP0915978B1 (de) 2005-12-14
WO1998002546A2 (en) 1998-01-22
DE69734882D1 (de) 2006-01-19
WO1998002546A3 (en) 1998-02-26
AU3431497A (en) 1998-02-09
DE69734882T2 (de) 2006-08-17
BR9712971A (pt) 2002-05-07
NZ334114A (en) 2000-06-23
JP2000503325A (ja) 2000-03-21
CA2259595A1 (en) 1998-01-22
CA2259595C (en) 2010-11-30
EP0915978A2 (de) 1999-05-19

Similar Documents

Publication Publication Date Title
DE69734882D1 (de) Dna immunisierung gegen chlamydia infektion
DE60038620D1 (de) Dna immunisierung gegen chlamydia infektion
DE69632536D1 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
DK0618976T3 (da) Syntetisk DNA-sekvens med forbedret insekticid virkning i majs
ITFI920052A1 (it) Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
DK1007686T3 (da) Tuberkulosevaccine
WO1999051745A3 (en) Dna immunization against chlamydia infection
GB9922361D0 (en) Generating an immune response to an antigen
ATE189961T1 (de) Impfstoff gegen mycobakterielle infektionen
DE69504959D1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ATE316577T1 (de) Das goodpasture-antigen bindende protein
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
BR9815496A (pt) Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório
DE69941099D1 (de) Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria
FI924494A0 (fi) Oekad produktion av avsoendrarde proteiner i eukaryotiska rekombinantceller
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
MXPA01001639A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
WO2000006739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000006743A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
EP1433843A3 (de) Xylanasen, für diese kodierende Gene und Anwendungen derselben
WO2001036457A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties